First Hearing for Actos Lawsuit

Actos Lawsuit

The first court hearing regarding an Actos lawsuit has been scheduled by a federal judge in Louisiana. The claim is that Actos, a diabetes drug, is related to an increased risk of bladder cancer.

U.S. District Judge Rebecca Doherty was assigned to preside over the many Actos lawsuits against Takeda Pharmaceuticals America, Inc., the makers of Actos.

Takeda’s parent company pulled the drug from shelves in Germany and France in 2011, but continued to sell the drug in the United States, despite the FDA warning announcing the possible risk of bladder cancer developing in Actos users.

According to an FDA spokeswoman, the Actos label has carried information about the possible risk of bladder cancer since it’s approval in 1999.

The Actos lawsuits claim that people who take Actos for over one year are facing an increased risk of bladder cancer. The suits also accuse the manufacturer of not sharing their knowledge about the risks associated with the use of Actos by failing to warn consumers and health care providers of the dangers of taking the drug.

Actos has been linked to an increased risk of bladder cancer. Anyone taking Actos for more than one year may face a 40% increase in the risk of developing bladder cancer.

Some of the severe and sometimes life threatening side effects of Actos include:

  • Bladder Cancer
  • Stomach pain
  • Nausea or vomiting
  • Blood in urine and/or painful urination
  • Shortness of breath and/or weakness
  • Rapid weight gain or swelling
  • Chest pain
  • Yellowing of the eyes or skin (Jaundice)
  • Skin easily bleeding or bruising
  • More Actos side effects

If you or a loved one has experienced severe side effects from the use of Actos, you may qualify for compensation to help with the cost of your medical expenses as well as your pain and suffering. To contact an Actos lawyer for a free consultation and Actos lawsuit information, call Matthews and Associates toll free at 1-888-520-5202.

Share